Thalidomide

DrugBank ID: DB01041

Summary

Metric	Value
Total Predictions	50
KG+DL (Dual Validated)	1
DL Only	49
KG Only	0

Predictions

Indication	Score	Source
ganglioneuroblastoma (disease)	0.9896	DL
vertebral anomalies and variable endocrine and T-cell dysfunction	0.9895	DL
retroperitoneal neoplasm	0.9868	DL
neuroblastoma	0.9866	DL
brachydactyly-syndactyly syndrome	0.9422	DL
colobomatous microphthalmia-rhizomelic dysplasia syndrome	0.9320	DL
rheumatoid arthritis	0.9240	DL
myeloid leukemia	0.9054	DL
indolent plasma cell myeloma	0.8846	DL
plasma cell myeloma	0.8534	KG+DL
acute lymphoblastic leukemia (disease)	0.7475	DL
cholangiocarcinoma, susceptibility to	0.6432	DL
GCGR-related hyperglucagonemia	0.6049	DL
scalp dermatosis	0.5990	DL
congenital temporomandibular joint ankylosis	0.5959	DL
polydipsia	0.5920	DL
mitral valve prolapse, myxomatous	0.5887	DL
epidural abscess	0.5797	DL
giant cell reparative granuloma	0.5702	DL
pancreas, dorsal, agenesis of	0.5694	DL
familial chronic myelocytic leukemia-like syndrome	0.5680	DL
ovarian fibroma (disease)	0.5633	DL
erythema nodosum, familial	0.5625	DL
atrial flutter (disease)	0.5612	DL
radiation proctitis	0.5584	DL
cloacogenic carcinoma	0.5571	DL
celiac artery stenosis from compression by median arcuate ligament of diaphragm	0.5553	DL
congenital cystic eye multiple ocular and intracranial anomalies	0.5546	DL
uterine cervix leukoplakia	0.5537	DL
trichoepitheliomas, multiple desmoplastic	0.5535	DL
milia, multiple eruptive	0.5531	DL
melanoma, malignant familial intraocular	0.5521	DL
hypospadias 3, autosomal	0.5521	DL
sella turcica, bridged	0.5521	DL
triphalangeal thumb, Nonopposable	0.5521	DL
intraductal tubulopapillary neoplasm of pancreas	0.5511	DL
prostate cancer, hereditary, X-linked	0.5505	DL
chemodectoma, intraabdominal, with cutaneous angiolipomas	0.5500	DL
lymphatic malformation 8	0.5499	DL
hemoglobin C-beta-thalassemia syndrome	0.5498	DL
hypercarotenemia and vitamin A deficiency, autosomal recessive	0.5468	DL
lymphoid system deterioration, progressive	0.5459	DL
polymorphic light eruption	0.5438	DL
low grade central osteosarcoma	0.5433	DL
Dyserythropoiesis, congenital, with ultrastructurally normal erythroblast heterochromatin	0.5426	DL
reactive arthritis	0.5426	DL
avascular necrosis	0.5424	DL
liver inflammatory myofibroblastic tumor	0.5422	DL
nonarteritic anterior ischemic optic neuropathy, susceptibility to	0.5421	DL
algoneurodystrophy	0.5413	DL

External Links

Disclaimer
Predictions are for research purposes only and do not constitute medical advice.